KG-1a Cells

The KG-1a cell line is a subline derived from the original KG-1 cell line, which was established from the bone marrow of a patient diagnosed with acute myeloid leukemia (AML). KG-1a cells are classified as a human myeloid leukemia cell line and are particularly characterized by their immature, undifferentiated state. Unlike the parent KG-1 cells, which are primarily in the myeloblast stage, KG-1a cells exhibit a more primitive phenotype, resembling early myeloid progenitors or even stem cells. This makes them an invaluable tool for studying hematopoiesis, leukemia progression, and the molecular mechanisms underlying myeloid differentiation.

KG-1a cells express various surface markers typical of early hematopoietic progenitors, such as CD34, CD38, and HLA-DR, while lacking markers associated with mature myeloid cells. This profile makes them highly suitable for research into stem cell biology and the development of leukemia therapies. Additionally, KG-1a cells are often used in drug screening assays to evaluate the efficacy of potential anti-leukemic compounds, particularly those targeting leukemic stem cells. Their ability to maintain an undifferentiated state in vitro also provides a robust model for gene expression studies and functional assays related to leukemia pathogenesis.

As with other cell lines derived from human tissue, KG-1a cells are intended for research use only and are not suitable for therapeutic or in vivo applications. They require careful handling under sterile conditions, and their growth characteristics necessitate specific culture conditions, including the use of RPMI-1640 medium supplemented with fetal bovine serum. Researchers utilizing the KG-1a cell line can gain significant insights into the early stages of leukemic transformation and the role of hematopoietic progenitors in cancer biology.